Abbott Sues Biovail Over Generic TriCor
Abbott Laboratories continues to fend off challenges to its blockbuster drug TriCor, accusing Biovail Corp. on Monday of infringing numerous patents when Biovail sought permission from federal regulators to market a...To view the full article, register now.
Already a subscriber? Click here to view full article